Holen Sie sich die Stockscreener-App
0.4473
4.81%
-0.0226
Schlusskurs vom Vortag:
$0.4699
Offen:
$0.47
24-Stunden-Volumen:
5.01M
Relative Volume:
0.18
Marktkapitalisierung:
$44.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.89M
KGV:
-0.1768
EPS:
-2.53
Netto-Cashflow:
$-11.95M
1W Leistung:
-8.97%
1M Leistung:
-38.79%
6M Leistung:
-63.03%
1J Leistung:
-68.72%
1-Tages-Spanne:
$0.4391
$0.4744
1-Wochen-Bereich:
$0.4391
$0.56
52-Wochen-Spanne:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Firmenname
Plus Therapeutics Inc
Sektor
Branche
Telefon
737.255.7194
Adresse
4200 MARATHON BLVD., AUSTIN, TX
Vergleichen Sie PSTV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.4473 | 45.87M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-03-17 | Eingeleitet | D. Boral Capital | Buy |
| 2021-01-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-16 | Eingeleitet | Maxim Group | Buy |
Plus Therapeutics Inc Aktie (PSTV) Neueste Nachrichten
Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
What is Plus Therapeutics Inc.’s valuation compared to sectorJuly 2025 Highlights & Consistent Profit Focused Trading Strategies - beatles.ru
Can machine learning forecast Plus Therapeutics Inc. recovery2025 Price Action Summary & High Return Trade Guides - Newser
Tick level data insight on Plus Therapeutics Inc. volatilityM&A Rumor & AI Driven Price Forecasts - Newser
Can Plus Therapeutics Inc. hit a new high this monthJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - Newser
Can Plus Therapeutics Inc. sustain its profitabilityEarnings Trend Report & Long-Term Safe Return Strategies - خودرو بانک
What is Plus Therapeutics Inc. s P E ratio telling usMarket Sentiment Report & Fast Gaining Stock Reports - خودرو بانک
Will Plus Therapeutics Inc. stock hit new highs in YEAR2025 Growth vs Value & Real-Time Market Sentiment Alerts - خودرو بانک
Can Plus Therapeutics Inc. benefit from deglobalizationJuly 2025 Institutional & Reliable Price Action Trade Plans - خودرو بانک
Growth Value: What is Plus Therapeutics Inc.’s valuation compared to sectorQuarterly Portfolio Review & Accurate Entry/Exit Alerts - خودرو بانک
Live market analysis of Plus Therapeutics Inc.Quarterly Growth Report & Capital Efficient Trading Techniques - Newser
What’s the recovery path for long term holders of Plus Therapeutics Inc. - Newser
Navigating Biotech Innovation Amid Sector Volatility: High-Conviction Opportunities in 2025 - AInvest
Is a relief rally coming for Plus Therapeutics Inc. holdersJuly 2025 Price Swings & Reliable Momentum Entry Alerts - Newser
Plus Therapeutics Inc. recovery potential after sell offTake Profit & Precise Swing Trade Entry Alerts - Newser
Plus Therapeutics Inc. stock trendline breakdownWeekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Plus Therapeutics, Inc. shares rise 2.22% premarket after HUTCHMED highlights clinical data at conference. - AInvest
Backtesting results for Plus Therapeutics Inc. trading strategiesGold Moves & Safe Capital Investment Plans - Newser
Should you wait for a breakout in Plus Therapeutics Inc.2025 Big Picture & Daily Stock Trend Watchlist - Newser
How to read the order book for Plus Therapeutics Inc.Quarterly Market Summary & Verified Chart Pattern Signals - Newser
Visualizing Plus Therapeutics Inc. stock with heatmapsJuly 2025 Reactions & Verified Swing Trading Watchlist - Newser
Is Plus Therapeutics Inc. building a consolidation baseJuly 2025 Sentiment & Weekly Market Pulse Alerts - Newser
Multi asset correlation models including Plus Therapeutics Inc.Profit Target & AI Enhanced Trading Alerts - Newser
Forecasting Plus Therapeutics Inc. price range with options dataWeekly Risk Summary & Precise Trade Entry Recommendations - Newser
How to integrate Plus Therapeutics Inc. into portfolio analysis toolsOil Prices & AI Driven Price Forecasts - Newser
Screener Results Flag Plus Therapeutics Inc. as Oversold2025 Risk Factors & Community Verified Watchlist Alerts - beatles.ru
Plus Therapeutics, Inc. shares rise 1.96% intraday after AC Immune's operational efficiencies and pipeline focus. - AInvest
Using data tools to time your Plus Therapeutics Inc. exitQuarterly Earnings Summary & Smart Swing Trading Techniques - Newser
Published on: 2025-09-04 04:06:08 - Newser
Building trade automation scripts for Plus Therapeutics Inc.Jobs Report & Verified Swing Trading Watchlist - Newser
What data driven models say about Plus Therapeutics Inc.’s future2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
How to forecast Plus Therapeutics Inc. trends using time seriesJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Chart overlay techniques for tracking Plus Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - Newser
Plus Therapeutics shares rise 4.68% intraday after announcing participation in H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital - Investing.com Canada
This BorgWarner Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Market reaction to Plus Therapeutics Inc.’s recent news2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Custom watchlist performance reports with Plus Therapeutics Inc2025 Historical Comparison & Weekly Watchlist for Hot Stocks - Newser
Plus Therapeutics Inc. stock momentum explainedMarket Weekly Review & Expert Curated Trade Ideas - Newser
What Fibonacci levels say about Plus Therapeutics Inc. rebound2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
What technical models suggest about Plus Therapeutics Inc.’s comebackWeekly Stock Analysis & Free Community Supported Trade Ideas - Newser
What moving averages say about Plus Therapeutics Inc.2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference - MarketScreener
Plus Therapeutics, Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference 2025 - Quiver Quantitative
CNS Cancer Drug Developer Plus Therapeutics Featured at Major H.C. Wainwright Investment Conference - Stock Titan
Ranking Plus Therapeutics Inc. among high performing stocks via toolsJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
Finanzdaten der Plus Therapeutics Inc-Aktie (PSTV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):